The GLP-1 Hair Loss Dilemma: What 50,000 Patients Reveal
A massive new BMJ study confirms a link between popular weight-loss drugs and alopecia, leaving millions wondering if the trade-off is worth it.
Browse the latest Tikva reporting, guides, and practical explanations.
A massive new BMJ study confirms a link between popular weight-loss drugs and alopecia, leaving millions wondering if the trade-off is worth it.
Rate volatility is extreme, the lock-in effect is easing, and late-summer economic shifts are imminent.
The American Society for Nutrition just released thousands of findings that rewrite the rules on ultra-processed foods, AI diets, and weight-loss drugs.
Microsoft and Meta report this week as markets demand proof that $700B in annual AI infrastructure spending is generating real returns.
A multistate Salmonella outbreak has sickened nearly 100 people. Here is exactly how to identify the recalled eggs, check the dates, and protect yourself.
Rocket Money excels at passive tracking and bill negotiation. If you want to change the behaviour that drives your spending, here are seven alternatives.
A practical guide to why pump prices remain high despite a US-Iran pause, and what Hormuz means for your wallet.
While oil and defense stocks surge amid the July 2026 US-Iran escalation, Bitcoin is exhibiting strange stability, redefining its digital gold narrative.
The July 27 selloff isn't about the Fed holding rates at 3.50–3.75% — it's about the bond market telling you megacap tech is overexposed.
As the fitness industry pivots toward recovery and longevity, low-intensity Zone 2 is officially dethroning high-intensity training.